Name | 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid |
---|---|
Synonyms |
DU-6859a
MFCD00903720 DU 6859a 7-((7S)-7-Amino-5-azaspiro[2.4]hept-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid 7-[(7S)-7-Amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid 7-[(7S)-7-Amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (1R-(1a(S*),2a))-7-(7-Amino-5-azaspiro[2.4]hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Gracevit 3-Quinolinecarboxylic acid, 7-[(7S)-7-amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo- Sitafloxacin |
Description | Sitafloxacin is a new-generation, broad-spectrum oral fluoroquinolone antibiotic.Target: AntibacterialSitafloxacin, a new-generation, broad-spectrum oral fluoroquinolone that is very active against many Gram-positive, Gram-negative and anaerobic clinical isolates, including strains resistant to other fluoroquinolones, was recently approved in Japan for the treatment of respiratory and urinary tract infections [1]. In terms of clinical efficacy, oral sitafloxacin was noninferior to oral levofloxacin in the treatment of community-acquired pneumonia or an infectious exacerbation of chronic respiratory tract disease, noninferior to oral tosufloxacin in the treatment of community-acquired pneumonia, and noninferior to oral levofloxacin in the treatment of complicated urinary tract infections, according to the results of randomized, double-blind, multicentre, noninferiority trials. Noncomparative studies demonstrated the efficacy of oral sitafloxacin in otorhinolaryngological infections, urethritis in men, C. trachomatis-associated cervicitis in women and odontogenic infections [2]. |
---|---|
Related Catalog | |
References |
[2]. Keating, G.M., Sitafloxacin: in bacterial infections. Drugs, 2011. 71(6): p. 731-44. |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 629.2±55.0 °C at 760 mmHg |
Molecular Formula | C19H18ClF2N3O3 |
Molecular Weight | 409.814 |
Flash Point | 334.3±31.5 °C |
Exact Mass | 409.100464 |
PSA | 88.56000 |
LogP | 0.87 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.699 |
Storage condition | 2-8°C |
~% 127254-12-0 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 20 p. 3344 - 3352 |
~% 127254-12-0 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 20 p. 3344 - 3352 |
~% 127254-12-0 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 20 p. 3344 - 3352 |
~% 127254-12-0 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 20 p. 3344 - 3352 |
~% 127254-12-0 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 20 p. 3344 - 3352 |
~% 127254-12-0 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 20 p. 3344 - 3352 |
Precursor 5 | |
---|---|
DownStream 0 |